Literature DB >> 21726568

Inactivation of EphA2 promotes tight junction formation and impairs angiogenesis in brain endothelial cells.

Na Zhou1, Wei-Dong Zhao, Dong-Xin Liu, Yue Liang, Wen-Gang Fang, Bo Li, Yu-Hua Chen.   

Abstract

Eph receptor tyrosine kinases and ephrin ligands participate in the regulation of a wide variety of biological processes, such as axon guidance, synaptic plasticity, angiogenesis, and tumorigenesis. The role of Eph receptors and ephrin ligands in brain endothelial cells remains unknown. Here, we examined the expression profile of EphA receptors and ephrin-A ligands in human brain microvascular endothelial cell line (HBMEC). Our results showed that multiple EphA receptors and ephrin-A ligands are expressed in HBMEC. We found that the phosphorylation of EphA2, but not other EphA receptors, was significantly increased in HBMEC treated with recombinant ephrin-A1/Fc. Meanwhile, elevated EphA2 phosphorylation was accompanied by disassembly of tight junctions in HBMEC. Furthermore, EphA2 RNAi in HBMEC could promote tight junction formation and prevent the ephrin-A1-induced tight junction disruption. Also, when a kinase-inactive mutant of EphA2 (EphA2-K646M) was expressed in HBMEC, the tight junction was enhanced and the ephrin-A1-induced tight junction disruption was blocked. In addition, EphA2 RNAi and expression of EphA2-K646M in HBMEC inhibited in vitro cell migration and angiogenesis of HBMEC. These data indicated an important role of EphA2 in regulating both tight junction formation and angiogenesis in brain endothelial cells. Crown
Copyright © 2011. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21726568     DOI: 10.1016/j.mvr.2011.06.005

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  25 in total

Review 1.  Therapeutic targeting of EPH receptors and their ligands.

Authors:  Andrew W Boyd; Perry F Bartlett; Martin Lackmann
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

2.  SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers.

Authors:  Sara Zanivan; Federica Maione; Marco Y Hein; Juan Ramon Hernández-Fernaud; Pawel Ostasiewicz; Enrico Giraudo; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2013-08-26       Impact factor: 5.911

3.  Transactivation of the receptor-tyrosine kinase ephrin receptor A2 is required for the low molecular weight hyaluronan-mediated angiogenesis that is implicated in tumor progression.

Authors:  Frances E Lennon; Tamara Mirzapoiazova; Nurbek Mambetsariev; Bolot Mambetsariev; Ravi Salgia; Patrick A Singleton
Journal:  J Biol Chem       Date:  2014-07-14       Impact factor: 5.157

4.  Dynamic regulation of VEGF-inducible genes by an ERK/ERG/p300 transcriptional network.

Authors:  Jason E Fish; Manuel Cantu Gutierrez; Lan T Dang; Nadiya Khyzha; Zhiqi Chen; Shawn Veitch; Henry S Cheng; Melvin Khor; Lina Antounians; Makon-Sébastien Njock; Emilie Boudreau; Alexander M Herman; Alexander M Rhyner; Oscar E Ruiz; George T Eisenhoffer; Alejandra Medina-Rivera; Michael D Wilson; Joshua D Wythe
Journal:  Development       Date:  2017-05-23       Impact factor: 6.868

5.  The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1).

Authors:  Bénédicte Foveau; Gaylor Boulay; Sébastien Pinte; Capucine Van Rechem; Brian R Rood; Dominique Leprince
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

6.  EphA2 proteomics in human keratinocytes reveals a novel association with afadin and epidermal tight junctions.

Authors:  Bethany E Perez White; Rosa Ventrella; Nihal Kaplan; Calvin J Cable; Paul M Thomas; Spiro Getsios
Journal:  J Cell Sci       Date:  2016-11-04       Impact factor: 5.285

7.  Effect of magnolol on cerebral injury and blood brain barrier dysfunction induced by ischemia-reperfusion in vivo and in vitro.

Authors:  Xiaoyan Liu; Xiaoling Chen; Yuanjun Zhu; Kewei Wang; Yinye Wang
Journal:  Metab Brain Dis       Date:  2017-04-04       Impact factor: 3.584

8.  The blood-brain barrier internalises Cryptococcus neoformans via the EphA2-tyrosine kinase receptor.

Authors:  Phylicia A Aaron; Mantana Jamklang; John P Uhrig; Angie Gelli
Journal:  Cell Microbiol       Date:  2018-01-18       Impact factor: 3.715

9.  Deletion of the EphA2 receptor exacerbates myocardial injury and the progression of ischemic cardiomyopathy.

Authors:  Wesley T O'Neal; William F Griffin; Susan D Kent; Filza Faiz; Jonathan Hodges; Jackson Vuncannon; Jitka A I Virag
Journal:  Front Physiol       Date:  2014-04-24       Impact factor: 4.566

10.  Evidence that the EphA2 receptor exacerbates ischemic brain injury.

Authors:  John Thundyil; Silvia Manzanero; Dale Pavlovski; Tanya R Cully; Ker-Zhing Lok; Alexander Widiapradja; Prasad Chunduri; Dong-Gyu Jo; Chie Naruse; Masahide Asano; Bradley S Launikonis; Christopher G Sobey; Mark G Coulthard; Thiruma V Arumugam
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.